Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 19 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

11%

2 trials in Phase 3/4

Results Transparency

18%

2 of 11 completed with results

Key Signals

2 with results100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (3)
P 1 (1)
P 2 (2)
P 4 (2)

Trial Status

Completed11
Not Yet Recruiting3
Recruiting2
Unknown1
Active Not Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (19)

Showing 19 of 19 trials
NCT06845345Phase 4Enrolling By Invitation

Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study)

NCT06062108Completed

Prevalence of Pain in Hospitalized Cirrhotic Patients

NCT07263152Phase 1CompletedPrimary

QTc Assessment in a Single-Dose Study of Hydronidone Capsules

NCT06599918Phase 2Recruiting

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

NCT06119997Not Yet RecruitingPrimary

Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care

NCT02446665Not ApplicableActive Not Recruiting

Disease Status in Primary Sclerosing Cholangitis by Elastography

NCT06739486Not Yet Recruiting

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

NCT06715189Not Yet RecruitingPrimary

Correlation Between Serum Adiponectin And Resistin Levels And Degree of Hepatic Fibrosis in MASlD With type2 Diabetes Mellitus

NCT05871749Completed

Effects of Hepatic Fibrosis on Hepatic Steatosis Using the Ultrasound Attenuation Imaging in Chronic Hepatitis B

NCT06252272Not ApplicableRecruitingPrimary

Generation of Organotypic Liver Cultures for the Identification of Biomarkers for the Prevention and Treatment of Liver Fibrosis

NCT01447667Not ApplicableCompletedPrimary

Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA)

NCT05383456Completed

The Visceral Adiposity Measurement and Observation Study

NCT02031913Completed

Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD

NCT02138253Phase 2Completed

A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV

NCT02372682Completed

Shear Wave Sonoelastography in Pediatric Liver Fibrosis

NCT02958592Completed

Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study

NCT01783314Phase 4UnknownPrimary

Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium

NCT00466271Completed

Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study

NCT00466336Completed

Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices

Showing all 19 trials

Research Network

Activity Timeline